Medicare Enrolled

Dr. Christopher Crosby, M.D., PH.D.

Dermatology · La Mesa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8860 CENTER DR, La Mesa, CA 91942
6194621670
In practice since 2008 (18 years)
NPI: 1497931380 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crosby from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crosby? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crosby

Dr. Christopher Crosby is a dermatology specialist in La Mesa, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Crosby performed 3,909 Medicare services across 2,545 unique beneficiaries.

Between the years covered by Open Payments, Dr. Crosby received a total of $3,098 from 37 pharmaceutical and/or device companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crosby is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 32% volume in CA $3,098 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,909
Medicare services
Top 32% in CA for dermatology
2,545
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~217 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
791 $6 $13
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
519 $59 $120
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
381 $45 $98
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
376 $530 $1,172
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 293 $368 $711
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
254 $69 $173
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
234 $39 $128
Complicated wound repair, 2.6-7.5 cm
A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet.
147 $216 $812
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
107 $35 $74
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
96 $202 $744
Skin growth removal and lab exam, 1-5 blocks
A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination.
82 $557 $1,104
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
75 $79 $230
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
59 $85 $188
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
44 $219 $550
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
41 $125 $340
Shaving of small skin growth on face or mouth area
A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth.
38 $80 $213
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
31 $80 $240
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
30 $110 $292
Additional Mohs surgery stage with microscopic exam
This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth.
28 $353 $683
Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm
A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters.
25 $218 $867
Destruction of small cancerous skin growth on face or mouth
This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth.
22 $106 $268
Skin growth shaving, 0.5 cm or less
This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs.
21 $66 $198
Skin graft repair, 10.1-30 sq cm
A surgical procedure to repair wounds on the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin. The graft covers an area between 10.1 and 30.0 square centimeters.
21 $764 $1,553
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
20 $71 $194
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals.
19 $96 $252
Shaving of skin growth, 0.5 cm or less
Removal of a small skin growth by shaving it off the surface. This procedure is performed on the scalp, neck, hands, feet, or genitals.
17 $73 $200
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
17 $101 $253
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
17 $140 $345
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
16 $108 $493
Surgical removal of skin cancer, 2.1-3.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters.
16 $130 $518
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals.
16 $129 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $85 $251
Skin graft repair of eyelid, nose, ear, or lip, 10.1-30 sq cm
This procedure involves repairing a wound on the eyelid, nose, ear, or lip by transferring skin from another area. The graft size covered is between 10.1 and 30.0 square centimeters.
14 $851 $1,649
Complex repair of eyelid, nose, ear, or lip wound, 1.1-2.5 cm
A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 1.1 and 2.5 centimeters.
13 $186 $727
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
13 $135 $328
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
0.5% medium
98.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,098
Total received (2018-2024)
Avg $443/year across 7 years
Top 37% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,975 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$953
2023
$595
2022
$595
2021
$299
2020
$94
2019
$296
2018
$266

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$164
Regeneron Healthcare Solutions, Inc.
$132
GENZYME CORPORATION
$116
Incyte Corporation
$101
Dermavant Sciences, Inc.
$58
REVANCE THERAPEUTICS, INC.
$48
ABBVIE INC.
$46
Organogenesis Inc.
$46
Lilly USA, LLC
$38
Galderma Laboratories, L.P.
$38
Almirall LLC
$35
STRATA Skin Sciences, Inc.
$31
LEO Pharma Inc.
$29
Amgen Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
UCB, Inc.
$20
Top 3 companies account for 43.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$316
Regeneron Healthcare Solutions, Inc.
$312
GENZYME CORPORATION
$295
E.R. Squibb & Sons, L.L.C.
$230
ABBVIE INC.
$125
Incyte Corporation
$122
Janssen Biotech, Inc.
$122
PFIZER INC.
$120
Genentech USA, Inc.
$119
MEDLINE INDUSTRIES LP
$116
AbbVie Inc.
$109
Almirall LLC
$96
MERZ NORTH AMERICA, INC.
$92
Organogenesis Inc.
$79
AbbVie, Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
DUSA Pharmaceuticals, Inc.
$65
Lilly USA, LLC
$64
Dermavant Sciences, Inc.
$58
PruGen, Inc. Pharmaceuticals
$57
LEO Pharma Inc.
$52
REVANCE THERAPEUTICS, INC.
$48
Sun Pharmaceutical Industries Inc.
$43
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Galderma Laboratories, L.P.
$38
STRATA Skin Sciences, Inc.
$31
Amgen Inc.
$27
Ortho Dermatologics, a division of Bausch Health US, LLC
$25
Allergan, Inc.
$25
UCB, Inc.
$20
Celgene Corporation
$19
Apyx Medical Corporation
$19
Stemline Therapeutics Inc.
$17
Allergan Inc.
$16
Sensus Healthcare, Inc.
$16
EPI Health, LLC
$15
Biofrontera Inc.
$15
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AMELUZ · Absorica LD · Aczone · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · Bimzelx · DAXXIFY · DUOBRII · DUPIXENT · ELZONRIS · ENSTILAR · EUCRISA · Erivedge · Humira · Klisyri · LIBTAYO · ODOMZO · OPZELURA · Otezla · Puraply · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · VTAMA · XTRAC
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in La Mesa?
Compare dermatologists in the La Mesa area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
236
Per 100K population
7.2
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Crosby is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Crosby experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Crosby performed 791 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crosby receive payments from pharmaceutical companies?
Yes. Dr. Crosby received a total of $3,098 from 37 companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crosby's costs compare to other dermatologists in La Mesa?
Dr. Crosby's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crosby) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →